Coherus Confirms Udenyca Launch And Brings In Chief Medical Officer

 
• By Dean Rudge

The California-based biosimilars player has come good on its promise to introduce early in the new year its first biosimilar in the US and the second biosimilar of Amgen’s Neulasta blockbuster; at the same time, biotech veteran Darlene Horton has joined Coherus’ management team.

SiliconValley
Coherus, based in Silicon Valley, has just rolled out Udenyca in the US • Source: Shutterstock

More from Products

More from Generics Bulletin